Investing.com - Financial Markets Worldwide
🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Stocks

Bio-View Ltd (BIOV)

Tel Aviv
Currency in ILS
27.9
+0.5(+1.82%)
Closed
BIOV Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
Unlock Value
Day's Range
27.628.7
52 wk Range
21.9343.9
Key Statistics
Edit
Bid/Ask
27.60 / 28.60
Prev. Close
27.4
Open
28.2
Day's Range
27.6-28.7
52 wk Range
21.9-343.9
Volume
97K
Average Volume (3m)
206.87K
1-Year Change
-16.97%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BIOV Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Technical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
pro lock
Unlock All 8
Holds more cash than debt on its balance sheet
Unlock InvestingPro

Bio-View Ltd News & Analysis

Show more

Bio-View Ltd Company Profile

Bio-View Ltd develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally. The company’s products include Accord, a workbench microscope station for semi-automated fluorescent imaging and analysis; Accord Plus, an automatic fluorescent imaging system that automatically scans, analyses, and sorts a range of FISH and Karyotype samples in real-time; and Allegro Plus, an automatic imaging system, which identifies various chromosomal aberrations under fluorescent light, such as amplifications, translocations, inversions, and deletions. It also offers DUET-3, an automated imaging system that supports multiple applications; Encore, an automated barcode reader, which enables scanning of various test types in a single scan batch; DeNovo, an automated scanning system for detection, analysis, and characterization of circulating tumor cells from peripheral blood; Solo Workstation, an offline workstation that streamlines and enables review and analysis of test results away from the microscope; Solo Touch Workstation, a stand-alone workstation that streamlines review and analysis of test results away from the microscope; and SoloWeb, a Web-based solution that provides analysis, reporting, and consulting on BioView-scanned cases. Bio-View Ltd has a partnership agreement with ANGLE plc to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was incorporated in 1998 and is headquartered in Rehovot, Israel.

Industry
Healthcare Equipment & Supplies
Sector
Healthcare
Employees
34
Market
Israel

Compare BIOV to Peers and Sector

Metrics to compare
BIOV
Peers
Sector
Relationship
P/E Ratio
39.2x−2.2x−0.6x
PEG Ratio
−0.91−0.060.00
Price/Book
1.2x0.9x2.6x
Price / LTM Sales
1.0x3.7x3.2x
Upside (Analyst Target)
-142.1%46.2%
Fair Value Upside
Unlock22.1%7.0%Unlock

FAQ

What Is the Bio View (BIOV) Stock Price Today?

The Bio View stock price today is 27.90

What Stock Exchange Does Bio View Trade On?

Bio View is listed and trades on the Tel Aviv stock exchange.

What Is the Stock Symbol for Bio View?

The stock symbol for Bio View is "BIOV."

What Is the Bio View Market Cap?

As of today, Bio View market cap is 36.45M.

What is Bio View Earnings Per Share?

The Bio View EPS is 0.007.

From a Technical Analysis Perspective, Is BIOV a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.